Osaic Holdings’s CollPlant Biotechnologies CLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184 Buy
345
+10
+3% +$10 ﹤0.01% 7575
2025
Q4
$469 Hold
335
﹤0.01% 7449
2025
Q3
$1.03K Hold
335
﹤0.01% 7337
2025
Q2
$455 Sell
335
-65
-16% -$135 ﹤0.01% 7369
2025
Q1
$1.03K Buy
400
+210
+111% +$740 ﹤0.01% 6805
2024
Q4
$684 Sell
190
-180
-49% -$732 ﹤0.01% 6935
2024
Q3
$1.79K Buy
370
+170
+85% +$832 ﹤0.01% 6656
2024
Q2
$994 Buy
+200
New +$1.11K ﹤0.01% 6819
2022
Q2
Sell
-248
Closed -$3K 7364
2022
Q1
$3K Hold
248
﹤0.01% 6713
2021
Q4
$4K Buy
+248
New +$4.43K ﹤0.01% 6734

Other funds holding CLGN

Osaic Holdings's CLGN Position: Q1 2026 in Review

Osaic Holdings increased its CollPlant Biotechnologies (CLGN) stake by 3% in Q1 2026, buying an estimated $10 and bringing the position to 345 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #7575.

Osaic Holdings first reported a position in CLGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $4K in Q4 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Osaic Holdings held 345 shares of CollPlant Biotechnologies worth $184 as of Q1 2026.
  • Osaic Holdings bought 10 CollPlant Biotechnologies shares in Q1 2026, an estimated $10.
  • CollPlant Biotechnologies made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7575 holding.
  • Osaic Holdings first reported a position in CollPlant Biotechnologies in Q4 2021 and has held it in 10 quarters since.
  • Osaic Holdings's CollPlant Biotechnologies position peaked at $4K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.